Plasma Brain Natriuretic Peptide-Guided Therapy to Improve Outcome in Heart Failure
The STARS-BNP Multicenter Study
Patrick Jourdain, MD*,
,
,*,
Guillaume Jondeau, MD, PhD
,
François Funck, MD
,
Pascal Gueffet, MD||,
Alain Le Helloco, MD¶,
Erwan Donal, MD¶,
Jean F. Aupetit, MD#,
Marie C. Aumont, MD
,
Michel Galinier, MD, PhD**,
Jean C. Eicher, MD
,
Alain Cohen-Solal, MD, PhD
and
Yves Juillière, MD, PhD
* René Descartes University, Paris, France
Georges Pompidou Hospital, Paris, France
Department of Cardiology, Bichat University Hospital, Paris, France

Department of Cardiology, Centre Hospitalier Universitaire de Lariboisière, Paris, France
Hospitalier de Rene Dubos, Pontoise, France
|| Centre Hospitalier Universitaire de Nantes, Nantes, France
¶ Centre Hospitalier Universitaire de Rennes, Rennes, France
# Hopital Saint Luc Lyon, Lyon, France
** Department of Cardiology, Centre Hospitalier Universitaire de Toulouse, Toulouse, France

Centre Hospitalier Universitaire de Dijon, Dijon, France

Department of Cardiology, Centre Hospitalier Universitaire de Vandoeuvre Les Nancy, Vandoeuvre Les Nancy, France.

View larger version (35K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 2 Changes in Medical Therapy During the Titration Phase in BNP Group and Clinical Group
Therapeutic modifications during titration phase. ACEI = angiotensin-converting enzyme inhibitor; BNP = brain natriuretic peptide.
|
|

View larger version (18K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 3 Evolution of Systolic Blood Pressure, Heart Rate, Weight, and Creatininemia During the First 3 Months
Hemodynamic and biological variations during titration phase. BNP = brain natriuretic peptide; M = month.
|
|
Copyright © 2007 by the American College of Cardiology Foundation.